NZ Colorectal Oncology Research Review Issue 30

In this issue:
  -  Screening for colorectal cancer
  -  Multitarget faecal immunochemical test for colorectal cancer screening
  -  HRQoL with pembrolizumab vs chemotherapy
  -  Regorafenib + avelumab for microsatellite stable colorectal cancer
  -  PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation
  -  COVID-19 impact on colorectal cancer diagnosis and management
  -  Circulating tumour DNA dynamics and recurrence risk
  -  Sorafenib + capecitabine for metastatic colorectal cancer
  -  Impact of IDEA collaboration study results on French clinical practice
  -  Impact of geography on prognostic outcomes in clinical trials

Please login below to download this issue (PDF)

Subscribe